'Taylor Swift is a Nazi' narrative boosted by coordinated online effort, new report finds Missing woman abducted over 40 years ago found alive How a Russian Jet Fighter Nearly Collided with Gigantic ...
Objectives: To compare the efficacy of intravitreal injection of aflibercept between the treat-and-extend (TAE) and pro re nata (PRN, as needed) regimens in the treatment of macular edema secondary to ...
WASHINGTON — It was March 2020 when veteran journalist Ryan Lizza found an apology note in his DC home that wasn’t meant for him. His live-in girlfriend, Olivia Nuzzi, had penned a letter on hotel ...
Eylea and Eylea HD are prescription medications used to treat various eye conditions. The dosage and frequency of injections of these drugs vary based on the specific condition and the form of the ...
Regeneron Pharmaceuticals is a leading biotech focused on gene editing. While the S&P 500 has dipped lower in November, Regeneron stock has climbed steadily higher. Despite its recent rise, Regeneron ...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...
Just as Adverum Biotechnologies' cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy. The prize for Lilly is ixo-vec, an ...
Peter Kaiser, MD, from Ocular Therapeutix, introduces OTX-TKI (Axpaxli), a novel tyrosine kinase inhibitor delivered through a proprietary hydrogel platform. This innovative treatment for wet ...
A new report out today from network security company Tenable Holdings Inc. details three significant flaws that were found in Google LLC’s Gemini artificial intelligence suite that highlight the risks ...
Background/aims Intravitreal injection (IVT) of anti-vascular endothelial growth factor agents is the standard of care for several retinal diseases but can cause intraocular pressure (IOP) elevations.
At the 131st Congress of the French Society of Ophthalmology in Paris, France, the role of second-generation intravitreal anti-VEGF injections compared to corticosteroid injections in treating ...
Regeneron Pharmaceuticals (NASDAQ:REGN) announced that the U.S. FDA has extended the target action dates for two regulatory submissions related to Eylea HD (aflibercept) injection 8 mg to the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results